HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rapid improvement in visual field defects following bromocriptine treatment of patients with non-functioning pituitary adenomas.

Abstract
The role of bromocriptine in the treatment of non-functioning pituitary tumours is not yet defined. Patients with these tumours who present with visual field defects usually undergo immediate surgery. Three consecutive patients are reported: each had rapid improvement in their visual field defects following bromocriptine 7.5 mg/d before surgery. Histological and immunohistochemical examination confirmed that their tumours were non-functioning chromophobe adenomas. Their responses indicate that bromocriptine may have a role in the management of some patients with non-functioning pituitary tumours.
AuthorsM C D'Emden, L C Harrison
JournalClinical endocrinology (Clin Endocrinol (Oxf)) Vol. 25 Issue 6 Pg. 697-702 (Dec 1986) ISSN: 0300-0664 [Print] England
PMID3652470 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Bromocriptine
Topics
  • Adenoma, Chromophobe (drug therapy)
  • Aged
  • Bromocriptine (therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pituitary Neoplasms (drug therapy)
  • Time Factors
  • Visual Fields

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: